blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1963503

EP1963503 - IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR PRODUCING THE SAME [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  12.11.2010
Database last updated on 08.11.2024
Most recent event   Tooltip12.11.2010Withdrawal of applicationpublished on 15.12.2010  [2010/50]
Applicant(s)For all designated states
KARP, M.D. Nelson M.
4837 Kempsville Greens Parkway
Virginia Beach, VA 23462 / US
[2008/36]
Inventor(s)01 / see applicant
...
 [2008/36]
Representative(s)Wibbelmann, Jobst
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstrasse 2
81541 München / DE
[N/P]
Former [2008/36]Wibbelmann, Jobst
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstrasse 2
81541 München / DE
Application number, filing date06845181.408.12.2006
[2008/36]
WO2006US47175
Priority number, dateUS20050749007P09.12.2005         Original published format: US 749007 P
[2008/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007067808
Date:14.06.2007
Language:EN
[2007/24]
Type: A2 Application without search report 
No.:EP1963503
Date:03.09.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 14.06.2007 takes the place of the publication of the European patent application.
[2008/36]
Search report(s)International search report - published on:US20.03.2008
(Supplementary) European search report - dispatched on:EP25.05.2010
ClassificationIPC:C12N15/00
[2008/36]
CPC:
A61K39/21 (EP,US); A61K39/12 (EP,US); A61P31/18 (EP);
C12N2740/16034 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/36]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:IMMUNOGENE ZUSAMMENSETZUNG AUF DER GRUNDLAGE EINES KONDITIONAL LEBENDEN VIRIONS UND VERFAHREN ZUR HERSTELLUNG DAVON[2008/36]
English:IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR PRODUCING THE SAME[2008/36]
French:COMPOSITION IMMUNOGENE BASEE SUR UN VIRION CONDITIONNELLEMENT VIVANT ET PROCEDE SERVANT A PRODUIRE CELUI-CI[2008/36]
Entry into regional phase30.06.2008National basic fee paid 
30.06.2008Search fee paid 
30.06.2008Designation fee(s) paid 
30.06.2008Examination fee paid 
Examination procedure09.07.2007Request for preliminary examination filed
International Preliminary Examining Authority: US
30.06.2008Amendment by applicant (claims and/or description)
30.06.2008Examination requested  [2008/36]
09.11.2010Application withdrawn by applicant  [2010/50]
Fees paidRenewal fee
30.12.2008Renewal fee patent year 03
17.12.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]WO9958726  (GENECURE LLC [US], et al) [X] 1-5 * the whole document * * page 3, line 9 - page 4, line 32 *[A] 6-15;
 [XA]EP1543837  (UNIV RUHR BOCHUM [DE]) [X] 1-5 * the whole document * * paragraph [[0019]] * * paragraph [[0075]] * [A] 6-15;
 [XI]  - DAS A T ET AL, "A CONDITIONALLY REPLICATING VIRUS AS A NOVEL APPROACH TOWARD AN HIV VACCINE", METHODS IN ENZYMOLOGY; [METHODS IN ENZYMOLOGY], ACADEMIC PRESS INC, SAN DIEGO, CA, US LNKD- DOI:10.1016/S0076-6879(04)88028-5, (20040101), vol. 388, ISSN 0076-6879, pages 359 - 379, XP008061959 [X] 1-5 * the whole document * [I] 6-15

DOI:   http://dx.doi.org/10.1016/S0076-6879(04)88028-5
 [XI]  - DAS ATZE T ET AL, "Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, (20021001), vol. 1, no. 3, ISSN 1476-0584, pages 293 - 301, XP009133123 [X] 1-5 * the whole document * [I] 6-15
 [XI]  - BERKHOUT BEN ET AL, "Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine", JOURNAL OF NEUROVIROLOGY, INFORMA HEALTHCARE, GB, (20021201), vol. 8, no. Suppl. 2, ISSN 1355-0284, pages 134 - 137, XP009133121 [X] 1-5 * the whole document * [I] 6-15
 [XI]  - DAS ATZE T ET AL, "Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry", JOURNAL OF VIROLOGY, (200503), vol. 79, no. 6, ISSN 0022-538X, pages 3855 - 3858, XP002581072 [X] 1-5 * the whole document * [I] 6-15

DOI:   http://dx.doi.org/10.1128/JVI.79.6.3855-3858.2005
 [XI]  - SMITH STEPHEN M ET AL, "Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine", JOURNAL OF BIOLOGICAL CHEMISTRY, (20010824), vol. 276, no. 34, ISSN 0021-9258, pages 32184 - 32190, XP002581073 [X] 1-5 * the whole document * [I] 6-15

DOI:   http://dx.doi.org/10.1074/JBC.M101604200
 [X]  - YAMAMOTO MASATO, "Conditionally replicative adenovirus for gastrointestinal cancers", EXPERT OPINION ON BIOLOGICAL THERAPY, INFORMA HEALTHCARE, UK, (20040801), vol. 4, no. 8, ISSN 1744-7682, pages 1241 - 1250, XP009133131 [X] 1-5 * the whole document *
International search[X]US2002193327  (NEMEROW GLEN R [US], et al);
 [Y]US2005112143  (KARP NELSON M [US]);
 [Y]US2005112139  (KARP NELSON M [US]);
 [Y]US2002009467  (KOYAMA SHOZO [JP], et al);
 [Y]US6585973  (LEES ANDREW [US]);
 [Y]US2004228925  (RIORDAN NEIL H [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.